Search Results - "Gu, Mi Li"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Preparation of a novel positively charged nanofiltration composite membrane incorporated with silver nanoparticles for pharmaceuticals and personal care product rejection and antibacterial properties by Huang, Zhong-Hua, Yin, Yan-Na, Aikebaier, Gu-li-mi-la, Zhang, Yan

    Published in Water science and technology (01-04-2016)
    “…A novel positively charged N-[(2-hydroxy-3-trimethylammonium)propyl] chloride chitosan (HTCC)-Ag/polyethersulfone (PES) composite nanofiltration membrane was…”
    Get full text
    Journal Article
  2. 2

    Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen by Gu, Mi-Li, Leppla, Stephen H, Klinman, Dennis M

    Published in Vaccine (28-01-1999)
    “…A DNA vaccine encoding the immunogenic and biologically active portion of anthrax protective antigen (PA) was constructed. Spleen cells from BALB/c mice…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The identification of the "Beijing family" strain of clinical isolated Mycobacterium tuberculosis in the south region of Xinjiang by Wu, Chang-dong, Wen, Shu, Mi, Li-gu, Cao, Hong-yan, Chen, Wei, Aierkenjiang, Zipaer, Gong, Tian-mei, Wang, Yuan-zhi, Li, Yong-xiang, Yuan, Li

    Published in Zhonghua jiehe he huxi zazhi (01-05-2010)
    “…To identify the Beijing family strain of Mycobacterium tuberculosis (M. tuberculosis) in order to find out the distribution of the Beijing family strain in the…”
    Get more information
    Journal Article
  5. 5

    Parvovirus H-1 P38 promoter requires the trans-activation region (tar), an SP1 site, and a TATA box for full activity by Gu, M L, Chen, F X, Rhode, S L

    Published in Virology (New York, N.Y.) (01-03-1992)
    “…In the parvovirus H-1 P38 promoter, there are sequences identified as a TATA box, an SP1 site, and a trans-activation responsive element (tar). It was…”
    Get more information
    Journal Article
  6. 6

    Trans-activation of H-1 parvovirus P38 promoter is correlated with increased binding of cellular protein(s) to the trans-activation responsive element (tar) by Gu, M L, Rhode, S L

    Published in Virology (New York, N.Y.) (01-09-1992)
    “…The parvovirus H-1 P38 promoter contains a trans-activation responsive element (tar). It was previously shown that the parvovirus H-1 nonstructural protein NS1…”
    Get more information
    Journal Article
  7. 7

    Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection by MI-LI GU, RHODE, S. L

    Published in Journal of Virology (01-03-1991)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1 by Gu, MiLi, Rappapor, Jay, Leppla, Stephen H.

    Published in FEBS letters (22-05-1995)
    “…The envelope glycoproteins of HIV are required for viral infectivity. Proteolysis of the precursor envelope glycoprotein gp160 results in the formation of…”
    Get full text
    Journal Article
  9. 9

    Development of an animal–human antibody complex for use as a control in ELISA by Gu, Mi Li, Feng, S.L., Glenn, J.K.

    “…In order to provide the equivalent of a human anti-human protein antibody as positive control in ELISAs, a goat–human antibody complex was created using…”
    Get full text
    Journal Article
  10. 10

    Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans by Sung, Cynthia, Parry, Tom J., Riccobene, Todd A., Mahoney, Angela, Roschke, Viktor, Murray, James, Gu, Mi Li, Glenn, Jeffrey K., Caputo, Florence, Farman, Cindy, Odenheimer, Daniel J.

    Published in AAPS PharmSci (01-01-2002)
    “…Repifermin (truncated, recombinant human keratinocyte growth factor-2, KGF-2) was evaluated in cynomolgus monkeys and healthy humans during a phase 1 trial…”
    Get full text
    Journal Article
  11. 11

    Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans by Sung, Cynthia, Parry, Tom J, Riccobene, Todd A, Mahoney, Angela, Roschke, Viktor, Murray, James, Gu, Mi Li, Glenn, Jeffrey K, Caputo, Florence, Farman, Cindy, Odenheimer, Daniel J

    Published in AAPS PharmSci (2002)
    “…Repifermin (truncated, recombinant human keratinocyte growth factor-2, KGF-2) was evaluated in cynomolgus monkeys and healthy humans during a phase 1 trial…”
    Get full text
    Journal Article